Jagsonpal Pharmaceuticals
add_icon

Jagsonpal Pharmaceuticals

232.89
-0.10
(-0.04%)
Market Cap
1,533.24 Cr
PE Ratio
33.77
Volume
51,421.00
Day High - Low
234.60 - 228.01
52W High-Low
264.50 - 155.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,533.24 Cr
EPS
6.40
PE Ratio
33.77
PB Ratio
5.56
Book Value
41.84
EBITDA
56.00
Dividend Yield
1.75 %
Industry
Healthcare
Return on Equity
23.07
Debt to Equity
0.04
Forecast For
Actual

Company News

View All News
Caret
positive
Jagsonpal Pharmaceuticals announces its 47th AGM on September 18, 2026. The company proposes a 200% dividend and completed a ₹40 crore share buyback. FY26 revenue rose 7% to ₹2,872 crore.
neutral
Jagsonpal Pharmaceuticals Limited has submitted its Business Responsibility and Sustainability Report for FY26. The filing highlights employee welfare, waste management, and stakeholder engagement metrics.
positive
Jagsonpal Pharmaceuticals reported a standalone net profit of ₹84.3 lakh for Q1FY27, up from a loss of ₹6.6 lakh in the same period last year. Revenue rose 44% YoY to ₹2,000.6 lakh.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,840.00
#1 4,41,477.63
36.91
#1 61,673.90
12.69
#1 11,565
26.53
34.00
9,322.00
2,47,469.81
85.36
11,067.00
13.95
2,568
65.50
63.65
4,965.50
1,88,871.66
86.95
13,886.20
20.34
2,138
3.28
52.16
1,119.10
1,12,607.65
24.28
27,657.90
17.64
5,026
-34.90
45.64
1,366.00
1,10,351.67
33.22
29,044.60
2.24
3,870
-39.18
35.27
1,969.00
1,06,297.76
95.94
6,867.80
22.01
890
#1 123.93
68.28
1,165.50
97,280.68
29.91
35,058.60
3.90
4,158
-69.10
47.72
1,679.80
96,651.98
25.88
34,145.20
5.56
3,503
25.21
57.04
2,095.00
95,790.22
#1 17.09
29,038.90
#1 26.75
5,356
16.00
28.17
2,280.00
94,163.08
44.87
14,636.40
14.85
1,938
29.13
37.57
Growth Rate
Revenue Growth
3.73 %
Net Income Growth
-19.98 %
Cash Flow Change
57.24 %
ROE
92.41 %
ROCE
81.03 %
EBITDA Margin (Avg.)
-12.57 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
138
144
144
127
168
161
192
221
242
218
277
287
306
Expenses
129
132
138
138
158
150
169
193
203
186
218
231
235
EBITDA
9
13
6
-11
11
11
24
29
40
32
59
56
71
Operating Profit %
6 %
8 %
4 %
-9 %
6 %
5 %
10 %
12 %
14 %
11 %
19 %
20 %
20 %
Depreciation
3
3
2
0
1
1
1
2
1
2
8
9
9
Interest
5
5
3
1
1
1
1
0
0
1
1
1
1
Profit Before Tax
2
4
14
-12
9
9
22
27
35
30
70
58
61
Tax
1
1
3
-0
2
2
5
8
8
7
15
13
14
Net Profit
1
3
12
-12
7
8
17
19
27
23
55
44
46
EPS in ₹
0.45
1.24
4.53
-4.41
2.75
3.00
6.51
7.20
10.20
3.40
8.26
6.40
6.80

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
154
159
143
130
136
147
164
164
195
217
278
317
Fixed Assets
52
52
22
21
22
22
26
23
24
9
95
85
Current Assets
96
101
110
95
98
95
121
109
165
197
161
143
Capital Work in Progress
0
0
0
3
4
4
0
0
0
0
0
0
Investments
0
0
0
0
0
11
15
51
1
0
0
15
Other Assets
102
108
121
106
110
109
123
91
170
208
184
0
Total Equity & Liabilities
154
159
143
130
136
147
164
164
195
217
278
317
Current Liabilities
55
57
29
29
28
33
40
27
28
19
26
28
Non Current Liabilities
4
4
3
3
3
3
2
5
9
11
12
12
Total Equity
95
98
110
98
105
111
122
133
159
187
240
276
Reserve & Surplus
82
85
97
85
91
98
109
120
146
174
226
263
Share Capital
13
13
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
2
1
5
-6
24
-1
19
-36
-12
2
-2
Investing Activities
-1
-2
41
-3
-1
-11
-2
-26
-58
-25
-45
Operating Activities
4
9
-3
-2
31
11
28
7
47
35
55
Financing Activities
-1
-6
-34
-1
-6
-1
-7
-18
-1
-9
-12

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
70.34 %
70.34 %
70.34 %
70.34 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.48 %
68.09 %
68.04 %
67.97 %
67.81 %
67.78 %
67.65 %
67.54 %
67.39 %
67.89 %
69.05 %
FIIs
0.00 %
0.00 %
0.11 %
0.20 %
0.00 %
0.00 %
0.13 %
0.00 %
0.00 %
0.00 %
0.38 %
0.00 %
0.73 %
1.10 %
2.30 %
2.10 %
2.10 %
2.18 %
2.12 %
2.12 %
2.44 %
2.30 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.28 %
0.77 %
0.83 %
0.83 %
0.83 %
0.00 %
0.85 %
0.85 %
0.11 %
0.00 %
0.00 %
0.05 %
0.09 %
0.15 %
0.22 %
0.62 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.67 %
26.08 %
23.71 %
23.71 %
22.92 %
25.27 %
22.78 %
21.11 %
22.23 %
22.84 %
21.99 %
21.94 %
20.69 %
20.79 %
20.38 %
20.64 %
20.94 %
24.26 %
21.13 %
21.20 %
20.73 %
19.33 %
Others
2.98 %
3.57 %
5.83 %
5.75 %
8.36 %
6.02 %
8.10 %
9.40 %
8.23 %
7.62 %
8.09 %
9.58 %
9.64 %
9.22 %
9.24 %
9.45 %
9.17 %
5.86 %
9.12 %
9.14 %
8.71 %
8.70 %
No of Share Holders
0
12,546
14,655
14,353
20,031
17,100
16,194
14,952
14,084
13,782
16,041
15,785
16,282
15,748
15,633
18,471
21,085
22,899
24,653
24,895
26,264
24,824

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.1 0.1 0.25 0.5 1 4 5 5 2.5 0.00
Dividend Yield (%) 0.93 0.95 3.56 1.57 0.8 3.45 4.52 2.3 1.36 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2026 230.70 232.99
24 Sept 2021 DIVIDEND Dividend
₹ 1.00 /share
22 Sept 2021 61.58 61.60
01 Nov 2021 DIVIDEND Dividend
₹ 4.00 /share
29 Oct 2021 64.92 70.02
17 Jun 2022 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
17 Jun 2022 118.06 112.10
21 Aug 2023 DIVIDEND Dividend
₹ 5.00 /share
21 Aug 2023 141.72 183.44
06 Sept 2024 DIVIDEND Dividend
₹ 5.00 /share
06 Sept 2024 144.50 166.92
18 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2024 144.82 164.04
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Oct 2024 181.94 182.48
08 Jan 2025 SPLIT Split
2:5
08 Jan 2025 182.48 260.80
22 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 Jan 2025 215.75 221.10
06 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 May 2025 232.70 249.91
26 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 Jul 2025 261.34 264.20
12 Sept 2025 DIVIDEND Dividend
₹ 2.50 /share
12 Sept 2025 249.91 248.60
24 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2025 264.20 241.85
03 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Nov 2025 215.59 222.70
21 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 Jan 2026 178.91 174.00
27 Apr 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Apr 2026 192.25 199.20
08 May 2026 BUYBACK Buyback
250
04 May 2026 209.79 214.03
29 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Jul 2026 221.55 224.06
04 Sept 2026 DIVIDEND Dividend
₹ 4.00 /share
04 Sept 2026 199.20 242.60

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 28, 2026
Notice Of 47Th Annual General Meeting And Annual Report For The FY 2025-26Aug 27, 2026
Business Responsibility and Sustainability Reporting (BRSR)Aug 27, 2026
Reg. 34 (1) Annual Report.Aug 27, 2026
Announcement Under Regulation 30-SEBI (LODR) Regulations 2015Aug 27, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 29, 2026
Corporate Action- Record Date: September 04 2026Jul 29, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 29, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 29, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJul 29, 2026
Unaudited Results For The Quarter Ended June 30 2026Jul 29, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On July 29 2026 Along With Unaudited (Standalone) Financial Results For The Quarter June 30 2026Jul 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 22, 2026
Board Meeting Intimation for Prior Intimation Of Board MeetingJul 22, 2026
General-UpdatesJul 17, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 15, 2026
General-UpdatesJul 08, 2026
General UpdatesJul 07, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 29, 2026
Announcement under Regulation 30 (LODR)-AcquisitionJun 29, 2026
Closure of Trading WindowJun 26, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 25, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJun 25, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 25, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 04, 2026
Announcement under Regulation 30 (LODR)-Closure of Buy BackJun 02, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 25, 2026
Post Buyback Public AnnouncementMay 25, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 18, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 07, 2026
Submission Of Letter Of Offer For Buy-Back Upto 1600000 Equity SharesMay 06, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 04, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 28, 2026
Corporate Action-Board approves DividendApr 27, 2026
Intimation Of Record Date For The Purpose Of Buy-Back Of Up To 1600000 Fully Paid-Up Equity Shares Of Face Value ?2/- Each At A Price Of ?250/- Per Share For An Aggregate Amount Not Exceeding ?40 CroresApr 27, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 27, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationApr 27, 2026
Corporate Action-Board to consider DividendApr 27, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 27, 2026
Audited Financial Results For The Year Ended March 31 2026Apr 27, 2026
Board Meeting Outcome for Outcome Of Board MeetingApr 27, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.03%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
46.42
ATR(14)
Less Volatile
8.42
STOCH(9,6)
Neutral
33.10
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-0.89
ADX(14)
Strong Trend
37.97
UO(9)
Bearish
40.64
ROC(12)
Downtrend And Accelerating
-3.50
WillR(14)
Oversold
-80.68